[EN] NOVEL COMPOUNDS AND THEIR USE<br/>[FR] NOUVEAUX COMPOSÉS ET LEUR UTILISATION
申请人:DEBIOPHARM INT SA
公开号:WO2021123372A1
公开(公告)日:2021-06-24
The present invention provides compounds of the general formula (I) or a pharmaceutically acceptable prodrugs, salts and/or solvates thereof, wherein LHS is selected from the group consisting of LHSa and LHSb And wherein, the asterisk (*) marks the point of attachment; These compounds exhibit antibacterial activity against Gram-negative and Gram-positive bacteria, especially S. aureus, E. coli, K. pneumoniae and A. baumannii. Pharmaceutical compositions containing these compounds, therapeutic uses thereof and methods for manufacturing the same are also provided.
本发明提供了一般式(I)的化合物或其药用可接受的前药、盐和/或溶剂化合物,其中LHS选自LHSa和LHSb组成的组,星号(*)标记附着点;这些化合物对革兰氏阴性和革兰氏阳性细菌,特别是金黄色葡萄球菌、大肠杆菌、肺炎克雷伯菌和鲍曼不动杆菌表现出抗菌活性。还提供了含有这些化合物的药物组合物、其治疗用途和制备方法。